Please use this identifier to cite or link to this item: doi:10.22028/D291-39926
Title: Evaluation of extraction methods for untargeted metabolomic studies for future applications in zebrafish larvae infection models
Author(s): Schippers, Philip
Rasheed, Sari
Park, Yu Mi
Risch, Timo
Wagmann, Lea
Hemmer, Selina
Manier, Sascha K.
Müller, Rolf
Herrmann, Jennifer
Meyer, Markus R.
Language: English
Title: Scientific Reports
Volume: 13
Issue: 1
Publisher/Platform: Springer Nature
Year of Publication: 2023
Free key words: Bioanalytical chemistry
Drug development
Mass spectrometry
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Sample preparation in untargeted metabolomics should allow reproducible extractions of as many molecules as possible. Thus, optimizing sample preparation is crucial. This study compared six diferent extraction procedures to fnd the most suitable for extracting zebrafsh larvae in the context of an infection model. Two one-phase extractions employing methanol (I) and a single miscible phase of methanol/acetonitrile/water (II) and two two-phase methods using phase separation between chloroform and methanol/water combinations (III and IV) were tested. Additional bead homogenization was used for methods III and IV (III_B and IV_B). Nine internal standards and 59 molecules of interest (MoInt) related to mycobacterial infection were used for method evaluation. Two-phase methods (III and IV) led to a lower feature count, higher peak areas of MoInt, especially amino acids, and higher coefcients of variation in comparison to one-phase extractions. Adding bead homogenization increased feature count, peak areas, and CVs. Extraction I showed higher peak areas and lower CVs than extraction II, thus being the most suited one-phase method. Extraction III and IV showed similar results, with III being easier to execute and less prone to imprecisions. Thus, for future applications in zebrafsh larvae metabolomics and infection models, extractions I and III might be chosen.
DOI of the first publication: 10.1038/s41598-023-34593-y
URL of the first publication: https://www.nature.com/articles/s41598-023-34593-y
Link to this record: urn:nbn:de:bsz:291--ds-399263
hdl:20.500.11880/35933
http://dx.doi.org/10.22028/D291-39926
ISSN: 2045-2322
Date of registration: 9-Jun-2023
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-023-34593-y/MediaObjects/41598_2023_34593_MOESM1_ESM.pdf
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
NT - Pharmazie
Professorship: M - Prof. Dr. Markus Meyer
NT - Prof. Dr. Rolf Müller
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s41598-023-34593-y.pdf2,57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons